Compare Cipla with Piramal Enterprises - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs PIRAMAL ENTERPRISES - Comparison Results

CIPLA     Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA PIRAMAL ENTERPRISES CIPLA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 29.6 -47.7 - View Chart
P/BV x 4.2 1.6 260.2% View Chart
Dividend Yield % 0.5 1.4 33.9%  

Financials

 CIPLA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    CIPLA
Mar-20
PIRAMAL ENTERPRISES
Mar-19
CIPLA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs5863,303 17.7%   
Low Rs3571,797 19.9%   
Sales per share (Unadj.) Rs207.0716.5 28.9%  
Earnings per share (Unadj.) Rs18.679.7 23.3%  
Cash flow per share (Unadj.) Rs33.2107.9 30.7%  
Dividends per share (Unadj.) Rs4.0028.00 14.3%  
Dividend yield (eoy) %0.81.1 77.3%  
Book value per share (Unadj.) Rs195.51,477.5 13.2%  
Shares outstanding (eoy) m806.35184.45 437.2%   
Bonus/Rights/Conversions ESOSIS-  
Price / Sales ratio x2.33.6 63.9%   
Avg P/E ratio x25.332.0 79.2%  
P/CF ratio (eoy) x14.223.6 60.1%  
Price / Book Value ratio x2.41.7 139.7%  
Dividend payout %21.535.1 61.2%   
Avg Mkt Cap Rs m379,912470,292 80.8%   
No. of employees `00025.87.8 330.5%   
Total wages/salary Rs m30,27022,504 134.5%   
Avg. sales/employee Rs Th6,459.616,899.4 38.2%   
Avg. wages/employee Rs Th1,171.22,877.7 40.7%   
Avg. net profit/employee Rs Th580.21,879.9 30.9%   
INCOME DATA
Net Sales Rs m166,949132,153 126.3%  
Other income Rs m3,4423,128 110.0%   
Total revenues Rs m170,391135,281 126.0%   
Gross profit Rs m32,06066,290 48.4%  
Depreciation Rs m11,7475,202 225.8%   
Interest Rs m1,97444,097 4.5%   
Profit before tax Rs m21,78220,119 108.3%   
Minority Interest Rs m-4753,194 -14.9%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,3128,611 73.3%   
Profit after tax Rs m14,99514,701 102.0%  
Gross profit margin %19.250.2 38.3%  
Effective tax rate %29.042.8 67.7%   
Net profit margin %9.011.1 80.7%  
BALANCE SHEET DATA
Current assets Rs m117,038122,742 95.4%   
Current liabilities Rs m43,931310,810 14.1%   
Net working cap to sales %43.8-142.3 -30.8%  
Current ratio x2.70.4 674.6%  
Inventory Days Days9623 414.9%  
Debtors Days Days8539 219.0%  
Net fixed assets Rs m107,424116,904 91.9%   
Share capital Rs m1,613369 437.1%   
"Free" reserves Rs m156,018272,161 57.3%   
Net worth Rs m157,630272,530 57.8%   
Long term debt Rs m23,693270,196 8.8%   
Total assets Rs m236,626856,261 27.6%  
Interest coverage x12.01.5 826.6%   
Debt to equity ratio x0.21.0 15.2%  
Sales to assets ratio x0.70.2 457.1%   
Return on assets %7.26.9 104.4%  
Return on equity %9.55.4 176.3%  
Return on capital %12.812.4 103.4%  
Exports to sales %33.00-   
Imports to sales %00-   
Exports (fob) Rs m55,175NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m56,03615,200 368.6%   
Fx outflow Rs m6,7644,889 138.4%   
Net fx Rs m49,27210,312 477.8%   
CASH FLOW
From Operations Rs m30,685-115,975 -26.5%  
From Investments Rs m1,040-8,265 -12.6%  
From Financial Activity Rs m-29,488107,525 -27.4%  
Net Cashflow Rs m2,340-16,650 -14.1%  

Share Holding

Indian Promoters % 16.0 52.9 30.2%  
Foreign collaborators % 20.8 0.0 -  
Indian inst/Mut Fund % 12.2 4.0 305.0%  
FIIs % 23.7 26.6 89.1%  
ADR/GDR % 1.1 0.0 -  
Free float % 26.2 16.5 158.8%  
Shareholders   161,166 93,274 172.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  WYETH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare CIPLA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tumbles 800 Points Tracking Global Selloff; Banking & Finance Stocks Bleed(09:30 am)

Asian stock markets opened sharply lower today after Wall Street's main indexes tumbled, with technology-related stocks under pressure following a steep rise in benchmark US Treasury yields.

Related Views on News

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CIPLA SHARE PRICE


Feb 26, 2021 10:14 AM

TRACK CIPLA

CIPLA - NEULAND LABS COMPARISON

COMPARE CIPLA WITH

MARKET STATS